Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYL7 |
| Upstream (Parents) |
|---|
| (<<) ATP7B → MYL7 |
| (<<) GBP2 → MYL7 |
| (<<) HLA-F → MYL7 |
| (<<) IRF1 → MYL7 |
| (<<) MAP3K10 → MYL7 |
| (<<) MT1F → MYL7 |
| (<<) PPRC1 → MYL7 |
| (<<) PRKCSH → MYL7 |
| (<<) PTGER4 → MYL7 |
| (<<) RPL26L1 → MYL7 |
| (<<) STAT1 → MYL7 |
| (<<) UBE2L6 → MYL7 |
| Downstream (Children) |
|---|
| MYL7 → CDC42 (>>) |
| MYL7 → CEND1 (>>) |
| MYL7 → FZD10 (>>) |
| MYL7 → GRB10 (>>) |
| MYL7 → HCN2 (>>) |
| MYL7 → MRAS (>>) |
| MYL7 → NPAS3 (>>) |
| MYL7 → WNT5B (>>) |
